Determination of viable myocardium through delayed enhancement cardiac magnetic resonance imaging combined with 18F-FDG PET myocardial perfusion/metabolic imaging before CABG
The International Journal of Cardiovascular Imaging · 2024
DOI: 10.1007/s10554-024-03057-3 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The International Journal of Cardiovascular Imaging, 2024. Verfasst von Dongsheng Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, TEDA International Cardiovascular Hospital, Tianjin, 300457, China. Hauptthemen laut MEDLINE: Predictive Value of Tests, Coronary Artery Bypass, Fluorodeoxyglucose F18, Myocardium. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Study aims to investigate the consistency of delayed enhancement cardiac magnetic resonance imaging (DE-CMR) and 18 F-FDG PET myocardial imaging in evaluating myocardial viability before CABG.
Methods
The study analyzed data from 100 patients who were examined with DE-CMR, PET imaging, and echocardiography before and after CABG. All subjects were followed up for 6–12 month post- CABG.
Results
DE-CMR and PET imaging have high consistency (90.1%; Kappa value = 0.71, p < 0.01) in determining myocardial viability. The degree of delayed enhancement was negatively correlated with the improvement in myocardial contractile function in this segment after revascularization ( P < 0.001). The ratio of scarred myocardial segments and total DE score was significantly lower in the improvement group than non-improvement group. Multivariate regression identified that hibernating myocardium (OR = 1.229, 95%CI: 1.053–1.433, p = 0.009) was influencing factor of LVEF improvement after CABG.
Conclusion
Both imaging techniques are consistent in evaluating myocardial viability. Detecting the number of hibernating myocardium by PET is also important to predict the left heart function improvement after CABG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, TEDA International Cardiovascular Hospital, Tianjin, 300457, China.
- Tianjin Key Laboratory of Molecular Regulation of Cardiovascular Diseases and Translational Medicine, Tianjin, 300457, China.
- Department of Nuclear Medicine, TEDA International Cardiovascular Hospital, Tianjin, 300457, China.
- Department of Radiology, TEDA International Cardiovascular Hospital, Tianjin, 300457, China. lijuanfan111@sina.com.
- Tianjin Key Laboratory of Molecular Regulation of Cardiovascular Diseases and Translational Medicine, Tianjin, 300457, China. lijuanfan111@sina.com.
Zitieren
APA
Xu, D., Zhang, J., Liu, B., Fu, D., Li, J., & Fan, L. (2024). Determination of viable myocardium through delayed enhancement cardiac magnetic resonance imaging combined with 18F-FDG PET myocardial perfusion/metabolic imaging before CABG. The International Journal of Cardiovascular Imaging. https://doi.org/10.1007/s10554-024-03057-3
Vancouver
Xu D, Zhang J, Liu B, Fu D, Li J, Fan L. Determination of viable myocardium through delayed enhancement cardiac magnetic resonance imaging combined with 18F-FDG PET myocardial perfusion/metabolic imaging before CABG. The International Journal of Cardiovascular Imaging. 2024. doi:10.1007/s10554-024-03057-3
BibTeX
@article{Xu2024,
author = {Xu, Dongsheng and Zhang, Jiwang and Liu, Bing and Fu, Donghai and Li, Jianming and Fan, Lijuan},
title = {Determination of viable myocardium through delayed enhancement cardiac magnetic resonance imaging combined with 18F-FDG PET myocardial perfusion/metabolic imaging before CABG},
journal = {The International Journal of Cardiovascular Imaging},
year = {2024},
doi = {10.1007/s10554-024-03057-3}
}
EUVIMED